Porzio Life Sciences Co-Sponsored, Presented at CBI's 5th Annual Global Transparency Reporting Congress
"Interpreting Lessons Learned from U.S. Open Payments Reporting (Sunshine Law) into Actionable Strategies for Managing HCP Relationships and Consent Agreements," 4:30 PM on Wednesday, April 15, 2015.
Panel Moderator: John Oroho
Panel Speaker: Brianna Pirmann
Guidelines regulating the disclosure of HCP spend are rapidly developing across the globe, including association codes that span across borders. Although laws are not in place in each country, the global nature of the bio/pharmaceutical and medical device industries mandate that companies meet these transparency requirements with total preparedness.
Discussion Items Included:
- Tracking HCP data
- Creating context for the information with effective communication
- Controlling spend on HCPs internally and through third-parties
- Implementing efficient systems and aligning goals across the company